Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow

Abstract

The aim of the present study was to determine if the human erythroid (E) and megakaryocytic (MK) lineages were closely linked to the existence of a bipotent burst-forming unit (BFU) E/MK progenitor. In methylcellulose cultures, BFU-E/MK colonies were observed at day 12 and closely resembled mature BFU-E with the exception that the erythroid component was surrounded by MK. These colonies were quite different from the colony forming unit (CFU)-GEMM-derived colonies, which were composed of a larger number of erythroblasts and which developed later in culture. The existence of these bilineage colonies composed of 100 to 1,000 erythroblasts intermingled with a few MK and without granulocytic cells was confirmed by the plasma clot technique and immunoalkaline phosphatase labeling of the MK. To investigate if this bipotent progenitor belonged to the compartment of primitive progenitors, CD34+ marrow cells were subfractionated according to expression of the CD38 antigen. The bipotent BFU-E/MK progenitor as well as a large fraction of MK progenitors were found in the CD34+ CD38+/- or in the CD34+ CD38- cell fractions. Growth of this bipotent BFU-E/MK progenitor required the combination of stem cell factor (SCF), Interleukin-3 (IL-3), and Epo in serum free conditions. Addition of IL- 6 had only a marginal effect, whereas megakaryocyte growth and development factor (MGDF) was not an absolute requirement, but slightly increased the plating efficiency of CFU-MK and of BFU-E/MK progenitors when combined with SCF, IL-3, and Epo. In contrast, when these cultures were performed in the presence of 30% fetal calf serum, no BFU-E/MK colonies were observed irrespective of the combination of growth factors used, including the presence of MGDF; however, inclusion of the MS-5 cell line restored the growth of this bipotent progenitor. In contrast, in cultures performed in the presence of human normal or aplastic plasma, MS-5 had only a slight effect on the cloning efficiency but improved MK cytoplasmic maturation and MK size, suggesting that the main effect of MS-5 is to diminish the inhibitory effect of the fetal calf serum on the MK differentiation. The clonal origin of bipotent BFU-E/MK colonies was demonstrated in liquid culture of single CD34+ CD38low cells by immunophenotyping individual clones. At day 12, 30% of the clones contained erythroblasts (glycophorin A+) and some MK (CD41+) without granulocytes (G) or macrophages (M) (CD14+ and CD15+). At day 20, clones containing erythroblasts and MK were rare (5%). In contrast multilineage clones could be frequently detected at this time without passage from BFU-E/MK clones at day 12 to GEMM at day 20. These results suggest that a bipotent BFU-E/MK progenitor may be a nonrandom step in the hierarchical development of stem cells.

Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin‐induced differentiation

“…Interestingly, the increase in megakaryocyte size and ploidy during the first year of age parallels the switching of haemoglobin from fetal to adult forms. It may be possible that shared transcriptional regulatory mechanisms are operating in megakaryocytes and erythrocytes during postnatal development, given the close relationship between both lineages (Romeo et al, 1990;Shivdasani et al, 1995;Debili et al, 1996;Kieran et al, 1996;Tsang et al, 1998;Vyas et al, 1999).…”

Molecular and Transcriptional Regulation of Megakaryocyte Differentiation

“…The most interesting functions of lineage-restricted transcription factors are exercised at the branch points of cellular hierarchies, where cell-specific programs of gene expression are activated or reinforced to permit emergence of a lineage identity. While there is increasing evidence that MKs derive from a bipotential erythro-MK progenitor [101], there are presently few clues about the transcriptional basis for defining the MK lineage. Perhaps most frustrating is the repeated observation that important aspects of differentiation of both erythroid cells and MKs depend, to varying degrees, on the same handful of hematopoietic transcription factors: GATA proteins, FOG-1, and NF-E2.…”

Recombinant human thrombopoietin (TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis

“…Erythrocytes and megakaryocytes have been postulated to derive from a common bi-potent progenitor cell (McDonald & Sullivan, 1993). Originally supported by indirect evidence, such as the simultaneous expression of erythroid (glycophorin A) and megakaryocyte (glycoprotein IIb/IIIa) lineage markers on primitive haemopoietic cells (Rowley et al, 1992), more direct proof of the existence of a common progenitor has recently been provided by cell cloning studies (Debili et al, 1996). Given the closeness of their origins, it may not be surprising that two of the major regulators of erythroid and megakaryocyte development, EPO and TPO, have been shown to have a high degree of amino terminal amino acid sequence homology (Lok et al, 1994).…”